User Name Password Remember Me
 
 
   
Video Podcast
Audio Cast
Mobile(WAP)
  Pedi Poll  
Should HIV testing be done only after informed written consent_?
Yes
No
  Translate This Page  
 
METHEMOGLOBINEMIA

Ira Shah
Consultant Pediatrician, Mumbai

Address for Correspondence: Dr Ira Shah, 1/B Saguna, 271/B St. Francis Road, Vile Parle (W), Mumbai 400056.

Abstract

Methoglobinemia is a condition in which ferrous iron within hemoglobin is oxidized to ferric iron resulting in impaired oxygen and carbon dioxide transport leading to cyanosis. It occurs as an acquired or congenital variant. Acquired methemoglobinemia occurs from exposure to oxidizing agents such as nitrates, nitrites, aniline dyes and medications such as lidocaine, prilocaine antimalarials. We report 1 14 months old girl with acquired methemoglobinemia who developed cyanosis after ingestion of potato wafers consisting of monosodium glutamate.

Introduction

Methemoglobinemia is a condition in which ferrous iron within hemoglobin is oxidized to ferric iron resulting in impaired oxygen and carbon dioxide transport leading to cyanosis. This ferric state leads to the formation of methemoglobin that causes brownish discoloration of the blood. In healthy normal children, the ferric iron is reduced to ferrous state by the aid of cytochrome b5 oxidase (methemoglobin reductase) along with other systems such as NADH reductase, glutathione reductase and Glucose-6-phosphate dehydrogenase (G-6-PD). Normal concentration of methemoglobin is maintained below 1% in healthy individuals by these enzyme systems (1). Methemoglobinemia occurs as an acquired or congenital variant. Acquired methemoglobinemia is more common and occurs from exposure to oxidizing agents such as nitrates, nitrites, aniline dyes and medications such as lidocaine, prilocaine antimalarials. Pyridium etc (2). It is seen more commonly in premature infants and infants younger than 4 months of age due to presence of fetal hemoglobin and decreased levels of NADH reductase at that age group. Congenital methemoglobinemia is due to either presence of altered hemoglobin (Hemoglobin M) or NADH reductase deficiency. Patients with congenital methemoglobinemia are generally asymptomatic other than cyanosis from birth. Acquired methemoglobinemia is usually mild but can be severe depending upon the cause and can present with cyanosis, dyspnea, lethargy-headache, dizziness and deterioration of mental functioning. A history of exposure to a known toxin or drug may be elicited. (1) We report a child with acquired methemoglobinemia who developed cyanosis after ingestion of potato wafers consisting of monosodium glutamate.

Case Report


A 14 months old girl born of non-consanguineous marriage presented with cyanosis since 1 day. This was preceded by 4-5 episodes of vomiting after ingestion of Potato wafers containing monosodium glutamate. On examination, she had central and peripheral cyanosis without tachypnea or tachycardia. Other systemic examination was normal. Her pulse oximetry revealed an oxygen saturation of 86%. Investigations showed hemoglobin of 10.5 gm% with normal white cell and platelet count. ABG showed hypoxia with normal pH [pO2 = 55.8, O2 Saturation = 88.3%]. Her methemoglobin levels was 44.5% (Normal = 0-2%). Thus, she was diagnosed as a case of Methemoglobinemia due to ingestion of monosodium glutamate. She was treated with Methylene Blue and Ascorbic Acid following which her Methemoglobin level fell to 14% after 2 days and 2% after 14 days.

Discussion

Methemoglobinemia can be easily diagnosed by pulse oximetry. The severity of cyanosis does not correspond to the pulse oximetry reading. The patient may appear extremely cyanotic but have a pulse oximetry reading in the high 80s. The arterial blood sample will show a normal PaO2 though the blood is chocolate brown. This blood when exposed to 100% oxygen continues to remain brown while deoxygenated blood changes to bright red. The diagnosis and severity of methemoglobinemia can be determined by methemoglobin levels. Methemoglobin levels greater than 1% are normal and symptomatic individuals usually have levels greater than 40-50%. (3)
Treatment consists of IV methylene blue (1-2 mg/kg) as a 1% solution over 5 minutes, repeated in our hour if necessary if methemoglobin levels are greater than 30%. Methylene blue is contraindicated in patients with G-6-PD deficiency as it can lead to severe hemolysis. Methylene blue is an oxidant at levels greater than 1 mg/kg and therefore can cause methemoglobinemia at higher doses. Ascorbic acid (200-500 mg) is found useful in congenital methemoglobinemia when methemoglobin level is above 30%. Rarely exchange transfusion may be required. Patients with acquired methemoglobinemia should avoid future exposure to precipitating agent. (4)

References

  1.
Conkling PR. Brown blood: understanding methemoglobinemia. N C Med J. Mar 1986; 47: 109-111. 
  2.
Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). 2004; 83: 265-273
  3..
Henretig FM, Gribetz B, Kearney T, Lacouture P, Lovejoy FH. Interpretation of color change in blood with varying degree of methemoglobinemia. J Toxicol Clin Toxicol. 1988; 26: 293-301.
  4.
Herman MI, Chyka PA, Butler AY, Rieger SE. Methylene blue by intraosseous infusion for methemoglobinemia. Ann Emerg Med. 1999; 33: 111-113

Last Updated on 01-09-2005 Vol 2 Issue 9 Art # 42

How to cite this url

Shah I. Methemoglobinemia.Pediatric Oncall [serial online] 2005 [cited 2005 September 1];2. Art # 42. Available from:

 
  Grants  
 » Apply For Research Grant
  Search  
Hospitals
Pediatrician
Special Schools
Medical Colleges
Pediatric Residency
Pediatric Conferences
Jobs & Vacancies
Journals
NGO's
  Ped Tools  
Pediatric Calculator
Drug Index
Medical Equipment
Vaccine Reminder
Adverse Drug Reactions
Biochemical Profile
Online MCQ's
  Calculators  
+ Growth
+ Conversion
+ Renal
+ Pregnancy
+ Blood Pressure
+ Blood Group
+ Critical Care
+ Drug Dose
+ Diarrhea Solution
+ Reference Values
+ Antibody Test
+ Drug Interaction
 
 
Parent Corner l Kids Corner l Terms & Condition l Privacy Statement | Advertising l Feedback | Awards
Newsletter | About Us l Link to Us l Site Map l Shopping Mall l Media Room  
Partner Sites
 HIV in Children  Infection in Children  Pedcall  Medical ADRIS  Vaccine Reminder  Pediatric Oncall Journal
Health Solutions from our sponsors
 Surfactant  Diarrhea  Nutrition      

Copyright© 2000-2008 All rights reserved with Pediatric Oncall

Disclaimer:The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitue an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.

 
Sitemap For Doctor | Sitemap For Parent | Sitemap For Kids Site designed and maintained by Levioza